Brief No. 1
Approved · Filed
One Gene Made Old Cells Act Younger — and Helped Mice Live Longer
Plesa, Jung, and colleagues, “Transcriptomic reprogramming screen identifies SRSF1 as a regulator of aging,” Nature Aging, October 14, 2026 · Wyss Institute at Harvard, led by George Church · Read the original paper
Researchers built a model that could estimate a cell’s age from its gene activity, then used it as a scoreboard to screen candidate genes. One stood out — SRSF1, a gene that helps cells edit their RNA messages. Dialed up in aged human skin cells, several hallmarks of aging eased. Delivered to aged mice, they aged more slowly and lived longer — and the refreshed cells kept their identity, which is the safety point that makes this lead worth watching.
The Finding: Frailty accumulated ~44% more slowly in treated mice; median lifespan 886 days vs. 778 — about 14% longer. The Limit: A small mouse study (10 treated, 9 control, all female); nothing here is human evidence. The Honest Read: A genuinely interesting lead, years from meaning anything for people — with a real cancer-safety question to answer first. There is nothing to buy or do.
Read the full Brief →
Educational content, not medical advice. House format: the finding · what it does not mean · the bottom line.
Brief No. 2
Approved · Runs Paired
More Than Half of “Healthy” Adults Already Have Plaque in Their Arteries
Bundgaard, García-Lunar, Kofoed, and colleagues, “Prevalence of Silent Atherosclerosis across Adult Life” (REACT), New England Journal of Medicine, August 29, 2026 · Rigshospitalet, Copenhagen, and CNIC, Madrid · DOI: 10.1056/NEJMoa2609059
Instead of estimating heart risk from a calculator, this study looked directly inside the arteries — imaging 16,808 adults aged 18 to 70 in Denmark and Spain who had no known heart disease and no symptoms. More than half of them — 57.1% — already had atherosclerotic plaque somewhere. About 1 in 13 under 30 had it; by 60 to 70, about 9 in 10 did. The standard risk calculator largely missed it, and a calcium score of zero did not rule plaque out.
The Finding: Silent plaque is the majority condition by middle age — it begins in the twenties, not at retirement. The Limit: A snapshot, not a forecast; prevalence is not destiny, and whether acting on silent plaque earlier prevents heart attacks is still being tested. The Honest Read: “Feeling fine” and “being clear” are two different statements — and the gap between them is worth knowing about.
How this Brief runs: published alongside Steve’s own imaging story — his scans, his numbers, told by the man himself. It never runs as a standalone scare. The evidence and the life arrive together, or not at all.
Educational content, not medical advice. This Brief recommends no scan, drug, or change for any reader; testing and treatment belong between a person and their own doctor.